Literature DB >> 11785676

Characterization of the rapid proteolytic shedding of murine L-selectin.

L C Zhao1, J B Edgar, M O Dailey.   

Abstract

The structural requirements for L-selectin shedding were studied in murine leukocytes. Upon activation, L-selectin on both lymphocytes and neutrophils undergoes cleavage by a membrane metalloprotease, resulting in the generation of a soluble ectodomain and a membrane-retained 6 kD fragment. Radiochemical sequencing demonstrated a cleavage site in the membrane-proximal region (MPR) between R321 and S322, which is homologous to the human site. Although intact neutrophil L-selectin is larger, it is cleaved at the same, or very close, site. Analysis of several transfectants expressing L-selectin point mutations and chimeric constructs suggest that, like human shedding, the proteolytic process has relatively loose sequence specificity for the substrate site. In addition, some constructs are susceptible to slow constitutive cleavage, but their shedding does not increase upon PMA stimulation, showing that basal and activated shedding are separable processes. Insertion of the 15 amino acid MPR into murine B7.2 conferred upon this molecule susceptibility to constitutive shedding. PMA stimulation results in little or no acceleration of down regulation of this molecule. These results suggest that recognition of both the membrane-proximal cleavage site and of a site distant from the MPR are required for maximal induction of L-selectin shedding.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11785676      PMCID: PMC2276085          DOI: 10.1155/2001/91831

Source DB:  PubMed          Journal:  Dev Immunol        ISSN: 1026-7905


  7 in total

1.  Dexamethasone enhances interaction of endogenous annexin 1 with L-selectin and triggers shedding of L-selectin in the monocytic cell line U-937.

Authors:  Catherine de Coupade; Egle Solito; Jon D Levine
Journal:  Br J Pharmacol       Date:  2003-08-11       Impact factor: 8.739

2.  Prospective Validation of CD-62L (L-Selectin) as Marker of Durable Response to Infliximab Treatment in Patients With Inflammatory Bowel Disease: A 5-Year Clinical Follow-up.

Authors:  Francisco Bravo; Jamie A Macpherson; Emma Slack; Nicolas Patuto; Julia Cahenzli; Kathy D McCoy; Andrew J Macpherson; Pascal Juillerat
Journal:  Clin Transl Gastroenterol       Date:  2021-02-15       Impact factor: 4.488

3.  Obesity Prolongs the Inflammatory Response in Mice After Severe Trauma and Attenuates the Splenic Response to the Inflammatory Reflex.

Authors:  Fabian Gärtner; Adrian Gihring; Aileen Roth; Joachim Bischof; Pengfei Xu; Leonard Elad; Martin Wabitsch; Timo Burster; Uwe Knippschild
Journal:  Front Immunol       Date:  2021-11-15       Impact factor: 7.561

4.  Induction of protective cytotoxic T-cell responses by a B-cell-based cellular vaccine requires stable expression of antigen.

Authors:  S Guo; J Xu; W Denning; Z Hel
Journal:  Gene Ther       Date:  2009-07-30       Impact factor: 5.250

5.  CD62L (L-selectin) shedding for assessment of perioperative immune sensitivity in patients undergoing cardiac surgery with cardiopulmonary bypass.

Authors:  Gabor Erdoes; Maria L Balmer; Emma Slack; Istvan Kocsis; Lutz E Lehmann; Balthasar Eberle; Frank Stüber; Malte Book
Journal:  PLoS One       Date:  2013-01-03       Impact factor: 3.240

6.  Inhibitors of selectin functions in the treatment of inflammatory skin disorders.

Authors:  Michael P Schön
Journal:  Ther Clin Risk Manag       Date:  2005-09       Impact factor: 2.423

7.  L-selectin shedding does not regulate constitutive T cell trafficking but controls the migration pathways of antigen-activated T lymphocytes.

Authors:  Elena Galkina; Kyriakos Tanousis; Graham Preece; Mauro Tolaini; Dimitris Kioussis; Oliver Florey; Dorian O Haskard; Thomas F Tedder; Ann Ager
Journal:  J Exp Med       Date:  2003-11-03       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.